Search results
4 days ago · Get a real-time Danaher Corporation (DHR) stock price quote with breaking news, financials, statistics, charts and more.
- 252.92-258.29
- 254.96
- 254.95
- 1,583,994
1 day ago · Latest Danaher Corp (DHR:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
3 days ago · The latest Danaher stock prices, stock quotes, news, and DHR history to help you invest and trade smarter.
- Danaher stock has received a consensus rating of buy. The average rating score is and is based on 48 buy ratings, 6 hold ratings, and 0 sell ratings.
- The low in the last 52 weeks of Danaher stock was 182.13. According to the current price, Danaher is 126.38% away from the 52-week low.
- The high in the last 52 weeks of Danaher stock was 247.36. According to the current price, Danaher is 93.05% away from the 52-week high.
- The 54 analysts offering price forecasts for Danaher have a median target of 283.22, with a high estimate of 365.00 and a low estimate of 205.00. T...
2 days ago · Get Danaher Corp (DHR) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
- 828-0850
6 days ago · View Danaher Corporation DHR stock quote prices, financial information, real-time forecasts, and company news from CNN.
Jun 24, 2024 · Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world.
People also ask
Where is Danaher Corporation DHR headquartered?
Who is Danaher Corporation?
What is the target price for Danaher (Danaher)?
What does Danaher do?
Jun 11, 2024 · 2023 Danaher Summit Highlight: Overcoming Barriers. June 11, 2024. New diagnostics can only benefit patients if they are reimbursed by payers, adopted by health systems and used by doctors. Our speakers describe the challenges of integrating new diagnostics into clinical practice.
